TRX-2

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameTRX-2
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCluster of differentiation 8 inhibitors
TargetsCluster of differentiation 8
Therapy Area/IndicationsRejection of organ transplantationLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTolerRx Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTolerRx Inc
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationLeukemia

Other Information

ATC CodeN/A
Related LinksN/A